Transcription of ICH Topic Q 3 A Impurities Testing Guideline: …
{{id}} {{{paragraph}}}
Example: marketing
ICH Topic Q 3 A Impurities Testing Guideline: …
The European Agency for the Evaluation of Medicinal ProductsHuman Medicines Evaluation UnitICH - Technical Coordination - R. Bass7 Westferry Circus, Canary Wharf, London E14 4HB, UKTel: (+44-171) 418 84 11 Fax: (+44-171) 418 85 51E_Mail: Topic Q 3 AImpurities Testing Guideline: Impurities in New DrugSubstancesStep 5 NOTE FOR GUIDANCE ON Impurities Testing : Impurities IN NEW DRUG SUBSTANCES (CPMP/ICH/142/95)APPROVAL BY CPMPMay 1995 DATE FOR COMING INTO OPERATION(STUDIES COMMENCING AFTER)1 November 1995 CPMP/ICH/142/951/11 Impurities IN NEW DRUG SUBSTANCESICH Harmonised Tripartite GuidelineTABLE OF of Impurities for the Reporting and Control of Impurities Organic Impurities Inorganic Impurities Solvents Impurity Content
CPMP/ICH/142/95 2/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline [EMEA Status as of May 1995] 1. PREAMBLE This document is intended to provide guidance for registration applications on the content and
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: